Recursion Pharmaceuticals, Inc.(RXRX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

RXRX Recursion Pharmaceuticals, Inc.

未开盘 05-12 16:00:00 EDT

4.64

+0.31

+7.16%

盘后4.62

-0.02-0.43%

19:56 EDT

最高4.68	最低4.41	成交量2,455万
今开4.63	昨收4.33	日振幅6.24%
总市值18.88亿	流通市值17.98亿	总股本4.07亿
成交额1.12亿	换手率6.34%	流通股本3.88亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"RXRX","market":"US","secType":"STK","nameCN":"Recursion Pharmaceuticals, Inc.","latestPrice":4.64,"timestamp":1747080000000,"preClose":4.33,"halted":0,"volume":24554355,"hourTrading":{"tag":"盘后","latestPrice":4.62,"preClose":4.64,"latestTime":"19:56 EDT","volume":386189,"amount":1781877.2223,"timestamp":1747094200707},"delay":0,"floatShares":387563212,"shares":406916486,"eps":-1.819511,"marketStatus":"未开盘","change":0.31,"latestTime":"05-12 16:00:00 EDT","open":4.63,"high":4.68,"low":4.41,"amount":112203408.72751501,"amplitude":0.062356,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.819511,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1747123200000},"marketStatusCode":0,"adr":0,"listingDate":1618545600000,"exchange":"NASDAQ","adjPreClose":4.33,"preHourTrading":{"tag":"盘前","latestPrice":4.64,"preClose":4.33,"latestTime":"09:29 EDT","volume":640115,"amount":2970309.3115675002,"timestamp":1747056580107},"postHourTrading":{"tag":"盘后","latestPrice":4.62,"preClose":4.64,"latestTime":"19:56 EDT","volume":386189,"amount":1781877.2223,"timestamp":1747094200707},"volumeRatio":0.936382,"impliedVol":0.8883,"impliedVolPercentile":0.54},"requestUrl":"/m/hq/s/RXRX/tweets","defaultTab":"tweets","newsList":[{"id":"2535761844","title":"Recursion Pharmaceuticals, Inc.5月12日成交额为1.12亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2535761844","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535761844?lang=zh_cn&edition=full","pubTime":"2025-05-13 11:05","pubTimestamp":1747105504,"startTime":"0","endTime":"0","summary":"美东时间2025年5月12日，Recursion Pharmaceuticals, Inc.成交额为1.12亿美元，成交额较昨日增加69.80%，当日成交量为2455.44万股。Recursion Pharmaceuticals, Inc.于2025年5月12日涨7.16%，报4.64美元，该股过去5个交易日跌2.52%，年初至今跌31.36%，过去60日跌45.41%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-05-12|1.12亿|69.80%|2455.44万|#|2025-05-09|6601.24万|-45.02%|1482.74万|#|2025-05-08|1.20亿|25.30%|2727.85万|#|2025-05-07|9581.93万|-31.17%|2254.69万|#|2025-05-06|1.39亿|-19.61%|3194.83万|Recursion Pharmaceuticals Inc是一家处于临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250513110512a47c1fbd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4609","BK4611","BK4548","RXRX","BK4139","BK4539"],"gpt_icon":1},{"id":"2534375271","title":"Recursion Pharmaceuticals, Inc.盘中异动 急速上涨5.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2534375271","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534375271?lang=zh_cn&edition=full","pubTime":"2025-05-12 21:43","pubTimestamp":1747057398,"startTime":"0","endTime":"0","summary":"北京时间2025年05月12日21时43分，Recursion Pharmaceuticals, Inc.股票出现异动，股价快速拉升5.79%。Recursion Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为2.86%。其相关个股中，Cytomx Therapeutics, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、艾吉纳斯涨幅较大，Nucana Plc、Cytomx Therapeutics, Inc.、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为380.20%、78.23%、60.14%，振幅较大的相关个股有Cytomx Therapeutics, Inc.、艾吉纳斯、奥麦罗制药，振幅分别为49.55%、29.55%、23.79%。Recursion Pharmaceuticals, Inc.公司简介：Recursion Pharmaceuticals Inc是一家处于临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250512214318a47b7b7d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4611","BK4539","RXRX","BK4609","BK4548","BK4139"],"gpt_icon":1},{"id":"2534114441","title":"Recursion Pharmaceuticals, Inc.5月8日成交额为1.20亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2534114441","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534114441?lang=zh_cn&edition=full","pubTime":"2025-05-09 10:42","pubTimestamp":1746758536,"startTime":"0","endTime":"0","summary":"美东时间2025年5月8日，Recursion Pharmaceuticals, Inc.成交额为1.20亿美元，成交额较昨日增加25.30%，当日成交量为2727.85万股。Recursion Pharmaceuticals, Inc.于2025年5月8日涨4.77%，报4.39美元，该股过去5个交易日跌20.18%，年初至今跌35.06%，过去60日跌42.69%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-05-08|1.20亿|25.30%|2727.85万|#|2025-05-07|9581.93万|-31.17%|2254.69万|#|2025-05-06|1.39亿|-19.61%|3194.83万|#|2025-05-05|1.73亿|50.92%|3451.17万|#|2025-05-02|1.15亿|59.45%|1985.76万|Recursion Pharmaceuticals Inc是一家处于临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509104226a6d8781c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4548","BK4539","BK4139","BK4609","RXRX","BK4611"],"gpt_icon":1},{"id":"2533939000","title":"Recursion Pharmaceuticals, Inc.盘中异动 股价大涨5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2533939000","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533939000?lang=zh_cn&edition=full","pubTime":"2025-05-07 22:02","pubTimestamp":1746626548,"startTime":"0","endTime":"0","summary":"北京时间2025年05月07日22时02分，Recursion Pharmaceuticals, Inc.股票出现异动，股价快速拉升5.13%。Recursion Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.35%。其相关个股中，Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Celularity Inc C/Wts 16/07/2026 、Osr Holdings Inc C/Wts 09/02/2028 涨幅较大，Theriva Biologics, Inc.、Zyversa Therapeutics, Inc.、Phio Pharmaceuticals Corp.较为活跃，换手率分别为1477.88%、1003.08%、170.17%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Celularity Inc C/Wts 16/07/2026 、Theriva Biologics, Inc.，振幅分别为57.00%、56.19%、44.12%。Recursion Pharmaceuticals, Inc.公司简介：Recursion Pharmaceuticals Inc是一家处于临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507220228a6d67157&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","RXRX","BK4611","BK4139","BK4548","BK4609"],"gpt_icon":1},{"id":"1197065634","title":"异动解读 | Recursion Pharmaceuticals盘中大跌5.15%，Q1业绩不及预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1197065634","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1197065634?lang=zh_cn&edition=full","pubTime":"2025-05-06 21:42","pubTimestamp":1746538928,"startTime":"0","endTime":"0","summary":"生物制药公司Recursion Pharmaceuticals今日盘中大跌5.15%，主要原因是公司公布的第一季度财报未能达到分析师预期。根据公司发布的财报，截至2025年3月31日的第一季度，Recursion Pharmaceuticals调整后每股亏损50美分，虽然略好于分析师平均预期的52美分亏损，但低于去年同期的39美分亏损。值得注意的是，Recursion Pharmaceuticals今年以来股价已累计下跌29.7%。这表明分析师对公司的长期发展仍持谨慎乐观态度，但短期内公司可能仍面临业绩压力。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"异动解读 | Recursion Pharmaceuticals盘中大跌5.15%，Q1业绩不及预期","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["RXRX"],"gpt_icon":1},{"id":"2533637929","title":"Recursion Pharmaceuticals, Inc.盘中异动 大幅下挫5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2533637929","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533637929?lang=zh_cn&edition=full","pubTime":"2025-05-06 21:31","pubTimestamp":1746538266,"startTime":"0","endTime":"0","summary":"北京时间2025年05月06日21时31分，Recursion Pharmaceuticals, Inc.股票出现异动，股价快速跳水5.05%。Recursion Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为2.50%。其相关个股中，Pasithea Therapeutics Corp.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Galmed Pharmaceuticals Ltd.涨幅较大，Pasithea Therapeutics Corp.、Galmed Pharmaceuticals Ltd.、Nucana Plc较为活跃，换手率分别为1475.26%、804.02%、197.34%，振幅较大的相关个股有Aspire Biopharma Holdings Inc C/Wts 14/02/2030 、Sensei Biotherapeutics, Inc.、Pasithea Therapeutics Corp.，振幅分别为11.79%、11.11%、9.85%。Recursion Pharmaceuticals, Inc.公司简介：Recursion Pharmaceuticals Inc是一家处于临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250506213106aa2c8418&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","BK4548","RXRX","BK4609","BK4611"],"gpt_icon":1},{"id":"2533300342","title":"Recursion Pharmaceuticals Q1 Loss Widens, Revenue Increases","url":"https://stock-news.laohu8.com/highlight/detail?id=2533300342","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533300342?lang=zh_cn&edition=full","pubTime":"2025-05-05 18:48","pubTimestamp":1746442092,"startTime":"0","endTime":"0","summary":"Recursion Pharmaceuticals  reported a Q1 net loss Monday of $0.50 per diluted share, widening from a loss of $0.39 a year earlier.Analysts polled by FactSet expected a loss of $0.39.Revenue for the quarter ended March 31 was $14.7 million, up from $13.7 million a year earlier.Analysts surveyed by FactSet expected $15 million.Recursion shares were down 4.5% in recent premarket activity.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"递归制药Q1亏损扩大，营收增长","themeId":"dfa009ab5530609aaf0d1c98097f8736","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["RXRX"],"gpt_icon":0},{"id":"2533302313","title":"Earnings Flash (RXRX) Recursion Pharmaceuticals Posts Q1 Revenue $14.7M, vs. FactSet Est of $15M","url":"https://stock-news.laohu8.com/highlight/detail?id=2533302313","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533302313?lang=zh_cn&edition=full","pubTime":"2025-05-05 18:13","pubTimestamp":1746439997,"startTime":"0","endTime":"0","summary":"Earnings Flash (RXRX) Recursion Pharmaceuticals Posts Q1 Revenue $14.7M, vs. FactSet Est of $15M","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"财报快讯(RXRX)Recursion Pharmaceuticals公布第一季度收入为1,470万美元，而FactSet预期为1,500万美元","themeId":"dfa009ab5530609aaf0d1c98097f8736","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["RXRX"],"gpt_icon":0},{"id":"2533630231","title":"Earnings Flash (RXRX) Recursion Pharmaceuticals Posts Q1 Net Loss $0.50 a Share, vs. FactSet Est of $0.39 Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2533630231","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533630231?lang=zh_cn&edition=full","pubTime":"2025-05-05 18:12","pubTimestamp":1746439950,"startTime":"0","endTime":"0","summary":"Earnings Flash (RXRX) Recursion Pharmaceuticals Posts Q1 Net Loss $0.50 a Share, vs. FactSet Est of $0.39 Loss","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"收益快讯(RXRX)Recursion Pharmaceuticals公布第一季度每股净亏损0.50美元，而FactSet预计亏损0.39美元","themeId":"dfa009ab5530609aaf0d1c98097f8736","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["RXRX"],"gpt_icon":0},{"id":"2533830235","title":"Recursion Pharmaceuticals Q1 EPS $(0.50) Beats $(0.52) Estimate, Sales $14.74M Miss $18.12M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2533830235","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533830235?lang=zh_cn&edition=full","pubTime":"2025-05-05 18:01","pubTimestamp":1746439299,"startTime":"0","endTime":"0","summary":"Recursion Pharmaceuticals (NASDAQ:RXRX) reported quarterly losses of $(0.50) per share which beat the analyst consensus estimate of $(0.52) by 3.85 percent. This is a 28.21 percent decrease over losses of $(0.39) per","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"Recursion Pharmaceuticals第一季度每股收益(0.50)美元超出预期(0.52)美元，销售额1,474万美元，低于预期1,812万美元","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/05/45189433/recursion-pharmaceuticals-q1-eps-0-50-beats-0-52-estimate-sales-14-74m-miss-18-12m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RXRX"],"gpt_icon":1},{"id":"2533303765","title":"Recursion Pharmaceuticals Reports Promising Early Results for Familial Adenomatous Polyposis Drug Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2533303765","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533303765?lang=zh_cn&edition=full","pubTime":"2025-05-05 16:10","pubTimestamp":1746432624,"startTime":"0","endTime":"0","summary":"Recursion Pharmaceuticals  said Sunday early results from a phase 1/2 trial of its drug REC-4881 for Familial Adenomatous Polyposis showed a median reduction in polyp burden of 43% after 13 weeks among six patients who were evaluated.The company said five patients saw polyp reductions between 31% and 82%, while one experienced a sharp increase compared to  20% to 30% reductions in other drugs over six months.Three patients also showed improvement in the Spigelman stage, while one worsened and two had mixed or unclear results.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"Recursion Pharmaceuticals报告家族性腺瘤性息肉病药物试验的早期结果令人鼓舞","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4611","BK4609","BK4539","RXRX","BK4548","BK4139"],"gpt_icon":1},{"id":"2526695843","title":"美股异动 | AI医药开发相关概念股大涨 Recursion Pharmaceuticals(RXRX.US)涨近23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2526695843","media":"智通财经","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2526695843?lang=zh_cn&edition=full","pubTime":"2025-04-11 22:11","pubTimestamp":1744380699,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，周五，AI医药开发相关概念股大涨，Recursion Pharmaceuticals(RXRX.US)涨近23%，Certara(CERT.US)涨超19%，Simulations Plus(SLP.US)涨超18%。消息面上，美国食品药品管理局(FDA)宣称，将在单抗等诸多药物方面逐步放弃动物试验路线，转而追求“更有效的人类相关研究方法”，计划使用AI替换动物实验。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1277701.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4548","BK4539","159938","BK4139","BK4609","RXRX","BK1515","BK1161","09939","BK4611","BK1574"],"gpt_icon":0},{"id":"1187977661","title":"美股夜盘 | 明星科技股跌势不减，特斯拉续跌超2%；FDA淘汰动物测试要求，概念股SLP大涨24%","url":"https://stock-news.laohu8.com/highlight/detail?id=1187977661","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1187977661?lang=zh_cn&edition=full","pubTime":"2025-04-11 08:16","pubTimestamp":1744330600,"startTime":"0","endTime":"0","summary":"本周五美股夜盘时段，明星科技股跌势不减， $特斯拉$ 续跌超2%， $博通$ 、 $英伟达$ 、 $Palantir Technologies Inc.$ 均跌近2%：因FDA淘汰动物测试要求，概念股 $Simulations Plus$ 夜盘大涨24%， $Recursion Pharmaceuticals, Inc.$ 涨超18%， $Certara, Inc.$ 涨超4%。美国食品药品监督管理局周四宣布，计划在单克隆抗体疗法及其他药物的研发过程中，采用与人类相关的方法来取代动物试验。美国食品药品监督管理局表示，将逐步取消动物试验的要求，转而采用基于人工智能的毒性计算模型、细胞系以及类器官毒性测试方法。","market":"us","thumbnail":"https://static.tigerbbs.com/5d1fe578ee46cbe0d24c33435ff25ae5","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/5d1fe578ee46cbe0d24c33435ff25ae5"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SLP","CERT","RXRX"],"gpt_icon":0},{"id":"1165955228","title":"美股AI医药开发概念股盘后上涨，美国FDA放弃动物试验原则","url":"https://stock-news.laohu8.com/highlight/detail?id=1165955228","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1165955228?lang=zh_cn&edition=full","pubTime":"2025-04-11 07:14","pubTimestamp":1744326887,"startTime":"0","endTime":"0","summary":" $Certara, Inc.(CERT)$（CERT）美股盘后涨24%， $Schrodinger Inc.(SDGR)$ （SDGR）涨16%， $Recursion Pharmaceuticals, Inc.(RXRX)$ （RXRX）涨20%， $Absci Corporation.(ABSI)$ （ABSI）涨12%， $查尔斯河(CRL)$ （CRL）涨超4%。消息面上，美国食品药品管理局（FDA）宣称，将在单抗等诸多药物方面逐步放弃动物试验路线，转而追求“更有效的人类相关研究方法”。","market":"hk","thumbnail":"https://static.tigerbbs.com/c5f6cd84096ca9b3b893fb788b76d134","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/c5f6cd84096ca9b3b893fb788b76d134"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"5edc5c21f4cbb4e30f295f21b2d83373","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"美国FDA放弃动物试验原则","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CERT","SDGR","RXRX","ABSI","CRL"],"gpt_icon":0},{"id":"2525876316","title":"Recursion Pharmaceuticals, Inc.4月4日成交额为1.21亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2525876316","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2525876316?lang=zh_cn&edition=full","pubTime":"2025-04-05 10:25","pubTimestamp":1743819945,"startTime":"0","endTime":"0","summary":"美东时间2025年4月4日，Recursion Pharmaceuticals, Inc.成交额为1.21亿美元，成交额较昨日增加34.31%，当日成交量为2814.93万股。Recursion Pharmaceuticals, Inc.于2025年4月4日跌11.85%，报4.24美元，该股过去5个交易日跌27.02%，年初至今跌37.28%，过去60日跌43.39%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-04-04|1.21亿|34.31%|2814.93万|#|2025-04-03|9003.39万|-1.59%|1837.06万|#|2025-04-02|9149.15万|4.93%|1750.31万|#|2025-04-01|8719.60万|-8.53%|1698.08万|#|2025-03-31|9533.21万|6.93%|1798.13万|Recursion Pharmaceuticals Inc是一家处于临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250405102551a6b040ca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RXRX","BK4609","BK4548","BK4539","BK4611"],"gpt_icon":1},{"id":"2524793264","title":"Recursion Pharmaceuticals, Inc.4月2日成交额为9149.15万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2524793264","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2524793264?lang=zh_cn&edition=full","pubTime":"2025-04-03 10:28","pubTimestamp":1743647292,"startTime":"0","endTime":"0","summary":"美东时间2025年4月2日，Recursion Pharmaceuticals, Inc.成交额为9149.15万美元，成交额较昨日增加4.93%，当日成交量为1750.31万股。Recursion Pharmaceuticals, Inc.于2025年4月2日涨3.83%，报5.29美元，该股过去5个交易日跌14.26%，年初至今跌21.75%，过去60日跌32.18%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-04-02|9149.15万|4.93%|1750.31万|#|2025-04-01|8719.60万|-8.53%|1698.08万|#|2025-03-31|9533.21万|6.93%|1798.13万|#|2025-03-28|8915.32万|-0.98%|1523.37万|#|2025-03-27|9003.18万|-4.26%|1474.17万|Recursion Pharmaceuticals Inc是一家处于临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250403102819a6adea77&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4611","RXRX","BK4609","BK4139","BK4548","BK4539"],"gpt_icon":1},{"id":"2524109669","title":"Recursion Pharmaceuticals, Inc.4月1日成交额为8719.60万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2524109669","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2524109669?lang=zh_cn&edition=full","pubTime":"2025-04-02 10:26","pubTimestamp":1743560778,"startTime":"0","endTime":"0","summary":"美东时间2025年4月1日，Recursion Pharmaceuticals, Inc.成交额为8719.60万美元，成交额较昨日减少8.53%，当日成交量为1698.08万股。Recursion Pharmaceuticals, Inc.于2025年4月1日跌3.69%，报5.1美元，该股过去5个交易日跌21.98%，年初至今跌24.63%，过去60日跌29.33%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-04-01|8719.60万|-8.53%|1698.08万|#|2025-03-31|9533.21万|6.93%|1798.13万|#|2025-03-28|8915.32万|-0.98%|1523.37万|#|2025-03-27|9003.18万|-4.26%|1474.17万|#|2025-03-26|9404.23万|19.63%|1510.92万|Recursion Pharmaceuticals Inc是一家处于临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250402102621a6aca106&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4609","BK4611","BK4548","RXRX","BK4539"],"gpt_icon":1},{"id":"2523654490","title":"Recursion Pharmaceuticals, Inc.3月28日成交额为8915.32万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2523654490","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2523654490?lang=zh_cn&edition=full","pubTime":"2025-03-29 10:22","pubTimestamp":1743214956,"startTime":"0","endTime":"0","summary":"美东时间2025年3月28日，Recursion Pharmaceuticals, Inc.成交额为8915.32万美元，成交额较昨日减少0.98%，当日成交量为1523.37万股。Recursion Pharmaceuticals, Inc.于2025年3月28日跌2.68%，报5.81美元，该股过去5个交易日跌13.02%，年初至今跌14.05%，过去60日跌14.18%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-03-28|8915.32万|-0.98%|1523.37万|#|2025-03-27|9003.18万|-4.26%|1474.17万|#|2025-03-26|9404.23万|19.63%|1510.92万|#|2025-03-25|7861.02万|-27.72%|1199.50万|#|2025-03-24|1.09亿|-8.64%|1603.37万|Recursion Pharmaceuticals Inc是一家处于临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250329102237a4460c93&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","RXRX","BK4139","BK4611","BK4548","BK4609"],"gpt_icon":1},{"id":"2522396693","title":"Recursion Pharmaceuticals, Inc.3月26日成交额为9404.23万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2522396693","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2522396693?lang=zh_cn&edition=full","pubTime":"2025-03-27 10:44","pubTimestamp":1743043449,"startTime":"0","endTime":"0","summary":"美东时间2025年3月26日，Recursion Pharmaceuticals, Inc.成交额为9404.23万美元，成交额较昨日增加19.63%，当日成交量为1510.92万股。Recursion Pharmaceuticals, Inc.于2025年3月26日跌5.51%，报6.17美元，该股过去5个交易日跌6.23%，年初至今跌8.73%，过去60日跌19.45%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-03-26|9404.23万|19.63%|1510.92万|#|2025-03-25|7861.02万|-27.72%|1199.50万|#|2025-03-24|1.09亿|-8.64%|1603.37万|#|2025-03-21|1.19亿|25.66%|1806.85万|#|2025-03-20|9472.97万|4.46%|1445.79万|Recursion Pharmaceuticals Inc是一家处于临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250327104416a6a57fc1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RXRX","BK4548","BK4139","BK4611","BK4609","BK4539"],"gpt_icon":1},{"id":"2519850063","title":"Recursion Pharmaceuticals, Inc.盘中异动 大幅跳水5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2519850063","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2519850063?lang=zh_cn&edition=full","pubTime":"2025-03-14 01:16","pubTimestamp":1741886211,"startTime":"0","endTime":"0","summary":"北京时间2025年03月14日01时16分，Recursion Pharmaceuticals, Inc.股票出现波动，股价快速下挫5.02%。Recursion Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.23%。其相关个股中，Apollomics Inc C/Wts 01/04/2028 、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Osr Holdings Inc C/Wts 09/02/2028 涨幅较大，Transcode Therapeutics, Inc.、Cervomed Inc.、Cero Therapeutics Holdings, Inc.较为活跃，换手率分别为1370.17%、663.48%、184.55%，振幅较大的相关个股有60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Tc Biopharm  Plc C/Wts 10/02/2028 、Cervomed Inc.，振幅分别为41.25%、37.89%、35.01%。Recursion Pharmaceuticals, Inc.公司简介：Recursion Pharmaceuticals Inc是一家处于临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250314011651a1db774a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4609","BK4539","BK4611","BK4548","RXRX","BK4139"],"gpt_icon":1}],"profile":{"websiteUrl":"http://www.recursion.com","stockEarnings":[{"period":"1week","weight":-0.0242},{"period":"1month","weight":-0.1944},{"period":"3month","weight":-0.3943},{"period":"6month","weight":-0.3661},{"period":"1year","weight":-0.4605},{"period":"ytd","weight":-0.3136}],"compareEarnings":[{"period":"1week","weight":0.0346},{"period":"1month","weight":0.0919},{"period":"3month","weight":-0.0369},{"period":"6month","weight":-0.0238},{"period":"1year","weight":0.1193},{"period":"ytd","weight":-0.0053}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Recursion Pharmaceuticals, Inc.最初成立于2013年11月4日，并在特拉华州注册成立 。 该公司是一家领先的临床阶段TechBio公司，将生物解码以将药物发现产业化。公司使命的核心是递归操作系统（OS），这是一个跨多种技术构建的平台，使公司能够在超过50 PB的专有数据中绘制和导航数万亿个以生物、化学和患者为中心的关系。该公司将物理和数字组件的这种集成框定为迭代循环，其中规模化的“湿实验室”生物学、化学和以患者为中心的实验数据由“干实验室”计算工具组织，以便识别、验证和翻译治疗见解。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.050758},{"month":2,"riseRate":0.5,"avgChangeRate":0.092727},{"month":3,"riseRate":0,"avgChangeRate":-0.270652},{"month":4,"riseRate":0.25,"avgChangeRate":-0.144468},{"month":5,"riseRate":0.4,"avgChangeRate":0.100754},{"month":6,"riseRate":0.5,"avgChangeRate":0.118076},{"month":7,"riseRate":0.75,"avgChangeRate":0.213595},{"month":8,"riseRate":0.25,"avgChangeRate":-0.10569},{"month":9,"riseRate":0.25,"avgChangeRate":-0.072683},{"month":10,"riseRate":0,"avgChangeRate":-0.131747},{"month":11,"riseRate":0.5,"avgChangeRate":0.076362},{"month":12,"riseRate":0.25,"avgChangeRate":0.027925}],"exchange":"NASDAQ","name":"Recursion Pharmaceuticals, Inc.","nameEN":"Recursion Pharmaceuticals, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.4","shortVersion":"4.33.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Recursion Pharmaceuticals, Inc.(RXRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Recursion Pharmaceuticals, Inc.(RXRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Recursion Pharmaceuticals, Inc.,RXRX,Recursion Pharmaceuticals, Inc.股票,Recursion Pharmaceuticals, Inc.股票老虎,Recursion Pharmaceuticals, Inc.股票老虎国际,Recursion Pharmaceuticals, Inc.行情,Recursion Pharmaceuticals, Inc.股票行情,Recursion Pharmaceuticals, Inc.股价,Recursion Pharmaceuticals, Inc.股市,Recursion Pharmaceuticals, Inc.股票价格,Recursion Pharmaceuticals, Inc.股票交易,Recursion Pharmaceuticals, Inc.股票购买,Recursion Pharmaceuticals, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Recursion Pharmaceuticals, Inc.(RXRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Recursion Pharmaceuticals, Inc.(RXRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}